Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GC1107 in healthy children
NCT01402713Phase 3Completed
- Sponsor
- GC Biopharma
- Start
- Aug 2011
- Primary completion
- Nov 2013
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of pegteograstim in diphtheria, Tetanus, sponsored by GC Biopharma. Started Aug 2011; status: completed.
02
Drugs
pegteograstim
03
Conditions
diphtheriaTetanus
Beyond the preview
Go deeper on NCT01402713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01402713.